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Summary 
It is crucial to remove dysfunctional mitochondria and peroxisomes to prevent cellular 
damage. Recent work suggests that under basal conditions USP30, a deubiquitinating 
enzyme, works to ensure that both these organelles are only turned over at the right time. 
Main Text 
Mitophagy, the autophagic delivery of mitochondria to lysosomes, is largely seen as a 
protective mechanism whereby dysfunctional mitochondria, which can release harmful 
reactive oxygen species (ROS), are degraded to prevent cellular damage [1, 2]. Mitophagy 
came to the centre stage when landmark studies showed that PINK1, a mitochondrial 
protein kinase, and Parkin, an E3 ubiquitin ligase, operate sequentially to tag mitochondria 
with a ubiquitin “eat-me” signal to enable specific mitochondrial engulfment by forming 
autophagosomes [3-5]. As PINK1 and Parkin can be mutated in hereditary Parkinson’s 
disease, this suggests that impaired mitophagy may play a disease role and that targeting it 
could prove therapeutically beneficial [6]. Ways to do this received a boost when it was 
shown that USP30, a mitochondrial deubiquitinase (DUB), could inhibit this pathway [7]: If 
the Parkin-derived mitochondrial ubiquitylation is the “on-switch” for mitophagy, then 
deubiquitylation will be the “off-switch”. Thus, inhibiting USP30 should enhance mitophagy 
and help clear dysfunctional mitochondria. Consequently, a deeper understanding of USP30 
regulation coupled with ways to target this protein is high on the research agenda. Recent 
work from Marcassa et al. [8] has delved more into the function of USP30 and revealed that 
even though USP30 regulates mitophagy, it may do so in an unexpected manner.  
Multiple mechanisms of mitophagy are emerging [2], but it is the aforementioned 
PINK1/Parkin-dependent pathway that has received the most attention. A significant body 
work (reviewed by Harper et al. [9]) has led to the following model. Upon mitochondrial 
depolarisation, PINK1 becomes stabilised on the outer mitochondrial membrane (OMM) 
and can then phosphorylate both ubiquitin and Parkin. Both these phosphorylation events 
are required for full Parkin activation, which then goes on to ubiquitylate multiple OMM 
substrates. The generated ubiquitin chains are further phosphorylated by PINK1, resulting in 
a feed-forward enhancement of Parkin activity and robust OMM ubiquitylation that in-turn 
acts as the “eat-me” signal for the autophagosome engulfment (Fig. 1A). It is at this 
ubiquitylation step that USP30 was first implicated as a negative regulator of mitophagy, 
with its overexpression or loss inhibiting or enhancing mitophagy respectively [7].  
There has been some debate however on the significance of the PINK1/Parkin pathway as 
the majority of experiments carried out have relied on cells overexpressing large amounts of 
Parkin coupled with harsh chemical mitochondrial depolarising agents. While this results in 
a striking and almost complete loss of mitochondria, which can easily be detected, it is hard 
to envision when and where such extreme scenarios might arise in vivo. Regardless, these 
experiments have been instrumental in elucidating the mechanisms of Parkin-driven 
mitophagy, with the caveat that overexpression artefacts could have clouded some data 
interpretation. The recent advent of more sensitive fluorescent probes has now allowed 
reliable assessment of mitophagy under more physiological conditions [10, 11]. Critically, 
these reporters have been used to generate mouse models that show mitophagy is indeed a 
physiological and pervasive process in mammals, making it reasonable to assume that its 
disruption will have impacts on cellular health and disease [12, 13]. Surprisingly though, loss 
of the PINK1/Parkin pathway in mice fails to have any notable difference on mitophagy 
under normal conditions [14], a fact that is also supported by a related study in flies [15]. 
While these findings highlight that the PINK1-Parkin pathway is not the major route for 
mitophagy in vivo, they do not mean it is not an important one. PINK1-dependent 
mitophagy may be a rare event, or only become relevant under distinct stress conditions. 
Thus, the search for the physiological significance of the PINK1/Parkin pathway is still 
ongoing. 
Given the above, Marcassa et al. investigated the cellular role of USP30 without Parkin 
overexpression and in the absence of acute chemical depolarisation [8]. Using the 
previously mentioned sensitive mitophagy reporter systems, the authors showed that the 
cellular loss of USP30 resulted in increased mitophagy, implying that ubiquitylation is indeed 
a key mitophagy signal. The immediate assumption that this was mediated by PINK1/Parkin 
activation did not hold true though, as loss of PINK1 alone in this system did not reduce 
basal mitophagy.  However, when the authors examined the loss of USP30 in the 
background of no PINK1, they found that the previously observed mitophagy increase was 
abolished. This could mean that loss of USP30 itself results in mitochondrial stress that 
activates the PINK1 pathway, or that PINK1 does play a role in basal mitophagy. The authors 
favour this latter scenario and have proposed that USP30 acts upstream of PINK1, rather 
than on the ubiquitin chains produced following activation of Parkin. The data support this 
hypothesis if the current model for Parkin activation holds true, in that it requires 
phosphorylation of pre-existing ubiquitin as well as that of Parkin itself. Thus, USP30 could 
be acting on the low level of pre-existing mitochondrial ubiquitylation and in this way 
prevents “tonic” activation of mitophagy: in essence it acts a safety catch to ensure 
mitophagy is not accidentally triggered under normal conditions (Fig. 1A).  
Like mitochondria, peroxisomes are also oxidative in nature due to fatty acid beta-oxidation 
and detoxification of hydrogen peroxide [16]. Hence the autophagy of peroxisomes, termed 
pexophagy, is thought to perform a similar role to mitophagy in that it can help eliminate 
dysfunctional or excess peroxisomes to limit the production of damaging ROS. The 
similarities do not end here as the basic mechanism of ubiquitylation as an autophagosome-
engulfment signal also appears to be conserved. Indeed, ectopic expression of peroxisomal 
proteins conjugated to ubiquitin is sufficient to trigger their delivery to lysosomes [17]. 
Unlike mitochondria though, PINK1 and Parkin are not thought to play a role in pexophagy, 
with the peroxisomal E3 ligase PEX2 implicated instead [18, 19]. If ubiquitylation is the key 
eat-me signal for peroxisomes then surely an “off-switch” or DUB will also be important in 
its regulation? The identity of such a DUB was not known but in the same USP30 study, 
Marcassa and colleagues noted that USP30 also localised to peroxisomes and its depletion 
also resulted in increased pexophagy (Fig. 1B). Peroxisomes though, have much closer 
relationship with mitochondria than just their common oxidative nature would suggest. 
Extensive contact sites exist between these organelles and recently mitochondria were 
shown to be involved in peroxisome generation [20]. Thus, it is possible that the observed 
increase in pexophagy upon loss of USP30 is an indirect effect of peroxisomes being in close 
association with mitochondria during mitophagy. Marcassa et al., took two approaches to 
help rule this out. Firstly, they were able to show that the peroxisomal and mitochondrial 
targeting of USP30 required distinct sequences around USP30’s transmembrane domain. 
Secondly, the authors used a neat trick to rid the cells of mitochondria. By taking advantage 
of the fact that Parkin overexpression, coupled with mitochondrial depolarisation, results in 
cellular depletion of this organelle, they were able to show that USP30 can still localise to 
peroxisomes independently of mitochondria. Thus, USP30 does appear to be a bone fide 
DUB regulating pexophagy as well as mitophagy. 
The conservation of USP30 mechanism in regulating both mitochondrial and peroxisomal 
autophagy pathways suggests that the turnover of these organelles could be co-ordinated 
under certain conditions. How this might proceed is currently unknown, as are the finer 
details of USP30 mechanism. What are the E3 ligases it opposes? For mitophagy, if it acts 
upstream of PINK1, this implies a ligase other than Parkin. In the case of peroxisomes, PEX2 
is a candidate but evidence for a USP30 link is lacking. Related, the actual ubiquitylated 
substrates are not clear as are the ubiquitin chain linkage types. Finally, USP30 has been 
proposed as a promising mitophagy-enhancing drug target. While the Marcassa study still 
supports such a role for USP30, it suggests that healthy mitochondria could be removed 
through enhancement of basal mitophagy and this may be less beneficial. Secondly, 
inhibiting USP30 will also result in pexophagy, which might have consequences in tissues 
such as liver and kidney where these organelles play an important role in detoxification. 
More work is obviously needed, but our knowledge of how organelles are turned over, and 
the consequences of this, is growing rapidly. Certainly, the complex interplay between 
ubiquitylation and deubiquitylation in these specific autophagy pathways is providing plenty 
of food for thought. 
 
Figure 1. USP30 reverses mitochondrial and peroxisomal ubiquitylation to prevent their 
autophagy. (A) USP30 removes the low level of mitochondrial ubiquitylation that occurs 
under basal conditions. This prevents activation of Parkin, excessive ubiquitylation and 
mitophagy should PINK1 become stabilised without robust mitochondrial depolarisation. (B) 
USP30 also limits pexophagy through peroxisome deubiquitylation, though the exact stage 
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